Skip to main content

Find Clinical Trials

Home
Conditions
BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm)

Clinical trial condition

BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm)

Explore clinical trials studying BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm) trial results

Recruiting

Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN

NCT06690827

Conditions: AML (Acute Myeloid Leukemia), BPDCN (blastic Plasmacytoid Dendritic Cell Neoplasm), Blastic Plasmacytoid Dendritic Cell Neoplasm, +14 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology. Wuhan, Hubei, China

View Trial Details